Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00197275
What this trial is testing

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 800
Large-scale testing (Phase 3)Looking for participantsNCT04166656
What this trial is testing

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

Who this might be right for
Splenectomy
Assistance Publique - Hôpitaux de Paris 84
Large-scale testing (Phase 3)Study completedNCT04368429
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi 360
Testing effectiveness (Phase 2)UnknownNCT06337071
What this trial is testing

The ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Large-scale testing (Phase 3)Study completedNCT00955682
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 342
Testing effectiveness (Phase 2)Study completedNCT01299480
What this trial is testing

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Who this might be right for
Meningococcal Vaccine
Pfizer 1,714
Not applicableEnded earlyNCT00465582
What this trial is testing

B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors

Who this might be right for
Meningococcal Infections
University Hospital, Rouen 3,296
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Large-scale testing (Phase 3)Study completedNCT04490018
What this trial is testing

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Who this might be right for
Meningococcal ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 463
Large-scale testing (Phase 3)Study completedNCT01148524
What this trial is testing

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 817
Testing effectiveness (Phase 2)Study completedNCT01442675
What this trial is testing

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 834
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Testing effectiveness (Phase 2)Study completedNCT01782066
What this trial is testing

Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines

Who this might be right for
Meningococcal Disease
Leiden University Medical Center 12
Large-scale testing (Phase 3)Looking for participantsNCT07505823
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Large-scale testing (Phase 3)Study completedNCT00310674
What this trial is testing

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Who this might be right for
Prevention of Meningococcal Infection
Novartis 150
Testing effectiveness (Phase 2)Study completedNCT00454909
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 873
Large-scale testing (Phase 3)Study completedNCT00463437
What this trial is testing

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Who this might be right for
Hepatitis BAcellular PertussisTetanus+3 more
GlaxoSmithKline 1,437
Next Page